| Trial ID: | L6321 |
| Source ID: | NCT05743907
|
| Associated Drug: |
Da-2811
|
| Title: |
Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus
|
| Interventions: |
DRUG: DA-2811|DRUG: Forxiga
|
| Outcome Measures: |
Primary: HbA1c(%), Change from baseline at 24 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Dong-A ST Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
231
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2023-04-25
|
| Completion Date: |
2025-03-10
|
| Results First Posted: |
|
| Last Update Posted: |
2025-03-14
|
| Locations: |
The Catholic University of Korea Bucheon St. Mary's Hospital, Bucheon, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT05743907
|
